1Neuromodulation Center and Center for Clinical Research Learning,Spaulding Rehabilitation Hospital and Massachusetts General Hospital, Harvard Medical School, 2Physical Therapy Department,Federal University of Sao Carlos, 3Vicerrectorado de Investigación,Universidad de Investigación para la Generación y Síntesis de Evidencia en Salud, Universidad San Ignacio de Loyola, 4Department of Medical Sciences, Graduate School of Medicine,Korea University, 5Neurive Co., Ltd., 6Department of Otorhinolaryngology-Head and Neck Surgery,Korea University Medical Center
This protocol provides information on how to apply transcutaneous auricular vagus nerve stimulation (taVNS) in a clinical trial, including potential biomarkers such as EEG metrics and heart rate variability (HRV) to measure the effect of this treatment on the autonomic nervous system.
